Page last updated: 2024-11-05

tetraethylammonium and Deafness

tetraethylammonium has been researched along with Deafness in 2 studies

Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)

Deafness: A general term for the complete loss of the ability to hear from both ears.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meşe, G1
Valiunas, V1
Brink, PR1
White, TW1
Hibino, H1
Horio, Y1
Inanobe, A1
Doi, K1
Ito, M1
Yamada, M1
Gotow, T1
Uchiyama, Y1
Kawamura, M1
Kubo, T1
Kurachi, Y1

Other Studies

2 other studies available for tetraethylammonium and Deafness

ArticleYear
Connexin26 deafness associated mutations show altered permeability to large cationic molecules.
    American journal of physiology. Cell physiology, 2008, Volume: 295, Issue:4

    Topics: Cell Line; Connexin 26; Connexins; Cyclic AMP; Deafness; Ethidium; Gap Junctions; Humans; Ion Channe

2008
An ATP-dependent inwardly rectifying potassium channel, KAB-2 (Kir4. 1), in cochlear stria vascularis of inner ear: its specific subcellular localization and correlation with the formation of endocochlear potential.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1997, Jun-15, Volume: 17, Issue:12

    Topics: 4-Aminopyridine; Action Potentials; Aging; Animals; Barium; Cochlear Duct; Deafness; DNA Primers; En

1997